2006
DOI: 10.1136/gut.2004.061010
|View full text |Cite
|
Sign up to set email alerts
|

Anti-ghrelin Spiegelmer NOX-B11 inhibits neurostimulatory and orexigenic effects of peripheral ghrelin in rats

Abstract: Background and aims: Ghrelin, the natural ligand of the growth hormone secretagogue receptor 1a, is the most powerful peripherally active orexigenic agent known. In rodents, ghrelin administration stimulates growth hormone release, food intake, and adiposity. Because of these effects, blocking of ghrelin has been widely discussed as a potential treatment for obesity. Spiegelmer NOX-B11 is a synthetic L-oligonucleotide, which was previously shown to bind ghrelin. We examined the effects of NOX-B11 on ghrelin in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
44
0
1

Year Published

2006
2006
2018
2018

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 64 publications
(46 citation statements)
references
References 34 publications
1
44
0
1
Order By: Relevance
“…Supportively, previous studies show that NOX‐B11‐2 decreased food intake in rodents via ghrelin‐dependent mechanisms (Kobelt et al., 2006; Shearman et al., 2006). In both rodents and humans, the plasma levels of ghrelin increase preprandially and thereby induce food intake (for review, see Egecioglu et al., 2011).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Supportively, previous studies show that NOX‐B11‐2 decreased food intake in rodents via ghrelin‐dependent mechanisms (Kobelt et al., 2006; Shearman et al., 2006). In both rodents and humans, the plasma levels of ghrelin increase preprandially and thereby induce food intake (for review, see Egecioglu et al., 2011).…”
Section: Discussionmentioning
confidence: 99%
“…1). In rats, a dose of 20 mg/kg (IP) was administrated since previous studies show that a similar dose reduces ghrelin‐induced food intake (Kobelt et al., 2006; Shearman et al., 2006). NOX‐B11‐2 was always administered IP 60 minutes prior to drug challenge as this is the time frame required for NOX‐B11‐2 to bind to circulating ghrelin and prevents its access to the brain (Shearman et al., 2006).…”
Section: Methodsmentioning
confidence: 99%
“…It blocks the biological effect by preventing ghrelin's activation of the endogenous receptor (Helmling et al 2004). The effects of ghrelin neutralization with NOX-B11(2) and related compounds on growth M a n u s c r i p t 6 hormone secretion, food intake and body weight gain in diet-induced obese mice were previously demonstrated (Helmling et al 2004;Kobelt et al 2006;Shearman et al 2006).…”
Section: Page 5 Of 37mentioning
confidence: 98%
“…Intravenous administration to rats of NOX-B11, a ghrelin spiegelmer, sup-pressed ghrelin-induced neuronal activity and ghrelin-induced food intake [126]. Another novel approach to reduce the effect of circulating ghrelin is the use of anti-ghrelin vaccines.…”
Section: Ghrelinmentioning
confidence: 99%